Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04186806 · ClinicalTrials.gov registry record · NA

Evaluation of the Efficacy of 3M Dry Mouth Moisturizing Spray

A NA study of Xerostomia, sponsored by Solventum US.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04186806 is a NA study of Xerostomia that has completed, run by Solventum US. The registered enrollment target is 40 participants, below the 92-participant average among 13 other Xerostomia trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04186806, a NA study of Xerostomia, has completed, sponsored by Solventum US.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of the clinical trial is to evaluate and validate the performance of the experimental mouth spray when used by persons with mild to severe dry mouth symptoms.

Conditions Studied

Interventions

  • DEVICE 3M Dry Mouth Moisturizing Spray to Biotene Moisturizing Mouth Spray
  • DEVICE Biotene Moisturizing Mouth Spray to 3M Dry Mouth Moisturizing Spray

Study Locations (1)

California

  • Loma Linda University, School of Dentistry - Loma Linda

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2019-11-02
Est. Completion 2019-12-13
Phase NA

Sponsor

Solventum US

41 total trials

What the Registry Record Tells You About NCT04186806

The ClinicalTrials.gov registry entry for NCT04186806 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 13 other Xerostomia trials with a reported enrollment target (57% lower). The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Xerostomia appearing as the primary indexed condition, and to 2 interventions - of which 3M Dry Mouth Moisturizing Spray to Biotene Moisturizing Mouth Spray is the first listed.

NCT04186806 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04186806 about?

NCT04186806 is a clinical study titled "Evaluation of the Efficacy of 3M Dry Mouth Moisturizing Spray". The purpose of the clinical trial is to evaluate and validate the performance of the experimental mouth spray when used by persons with mild to severe dry mouth symptoms.

What is the current status of trial NCT04186806?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-11-02. Estimated completion is 2019-12-13.

What conditions does trial NCT04186806 study?

This clinical trial studies the following conditions: Xerostomia.

What interventions are being tested in trial NCT04186806?

The interventions under investigation include: 3M Dry Mouth Moisturizing Spray to Biotene Moisturizing Mouth Spray (DEVICE), Biotene Moisturizing Mouth Spray to 3M Dry Mouth Moisturizing Spray (DEVICE).

Who is sponsoring clinical trial NCT04186806?

This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04186806 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Xerostomia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.